Skip to main content

Table 5 Mean mental component summary scores reported at each visit by participant group

From: Health-related quality of life and tuberculosis: a longitudinal cohort study

Visit

Crude estimate

Adjusted estimate a

95% Confidence interval adjusted estimate

P-value*

Baseline

    

Tuberculosis disease

47.1

46.4

44.1 - 48.8

<0.01*

Latent tuberculosis infection

50.5

50.5

48.5 - 52.4

0.07

Controlb

51.7

51.1

48.9 - 53.2

-

1 month of treatment

   

Tuberculosis disease

50.7

50.1

47.5 - 52.6

0.69

Latent tuberculosis infection

50.2

50.2

48.0 - 52.3

0.72

Control

51.5

50.8

48.6 - 53.1

-

2 months of treatment

   

Tuberculosis disease

51.8

51.3

48.8 - 53.7

0.75

Latent tuberculosis infection

50.5

50.6

48.5 - 52.8

0.86

Control

51.7

51.2

49.2 - 53.2

-

4 months of treatment

   

Tuberculosis disease

50.8

50.3

47.7 - 52.9

0.67

Latent tuberculosis infection

50.9

51.0

48.8 - 53.1

0.67

Control

51.9

51.4

49.1 - 53.8

-

6 months of treatment

   

Tuberculosis disease

51.7

51.2

48.6 - 53.8

0.50

Latent tuberculosis infection

50.7

50.7

48.5 - 53.0

0.52

Control

51.5

51.0

48.7 - 53.4

-

9 months of treatment

   

Tuberculosis disease

54.0

53.6

50.9 - 56.4

0.88

Latent tuberculosis infection

50.5

50.5

48.1 - 52.9

0.71

Control

51.4

51.0

48.5 - 53.5

-

12 months of treatment

   

Tuberculosis disease

54.0

53.6

50.7 - 56.5

0.28

Latent tuberculosis infection

50.9

50.9

48.6 - 53.2

0.30

Control

52.2

51.7

49.3 - 54.2

-

  1. aAdjusted models comparing participants treated for tuberculosis disease to those participants in the untreated control group controlled for age at baseline and sex. Adjusted models comparing participants treated for latent tuberculosis infection to those participants in the untreated control group controlled for age at baseline and sex.
  2. bControl is a participant screened for tuberculosis who tested negative for tuberculosis and was found not to require treatment.
  3. *Indicates a p-value less than 0.05 meaning a statistically significant difference in mean mental component summary scores reported by the group of treated participants and the participants in the control group in the adjusted model, at the given visit.